Pulmonx Corporation
LUNG
$1.58
-$0.01-0.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 90.55M | 87.47M | 83.79M | 79.30M | 76.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 90.55M | 87.47M | 83.79M | 79.30M | 76.58M |
| Cost of Revenue | 24.39M | 23.21M | 21.79M | 20.49M | 19.77M |
| Gross Profit | 66.16M | 64.27M | 62.00M | 58.81M | 56.81M |
| SG&A Expenses | 105.27M | 103.88M | 102.14M | 99.55M | 98.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 147.46M | 145.20M | 141.49M | 137.51M | 135.84M |
| Operating Income | -56.91M | -57.73M | -57.70M | -58.21M | -59.25M |
| Income Before Tax | -56.40M | -56.64M | -55.89M | -56.40M | -57.29M |
| Income Tax Expenses | 542.00K | 449.00K | 500.00K | 710.00K | 577.00K |
| Earnings from Continuing Operations | -56.94 | -57.09 | -56.39 | -57.11 | -57.86 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.94M | -57.09M | -56.39M | -57.11M | -57.86M |
| EBIT | -56.91M | -57.73M | -57.70M | -58.21M | -59.25M |
| EBITDA | -55.64M | -56.36M | -56.19M | -56.70M | -57.73M |
| EPS Basic | -1.43 | -1.45 | -1.44 | -1.47 | -1.50 |
| Normalized Basic EPS | -0.89 | -0.90 | -0.89 | -0.91 | -0.93 |
| EPS Diluted | -1.43 | -1.45 | -1.44 | -1.47 | -1.50 |
| Normalized Diluted EPS | -0.89 | -0.90 | -0.89 | -0.91 | -0.93 |
| Average Basic Shares Outstanding | 159.24M | 157.76M | 156.44M | 155.23M | 154.08M |
| Average Diluted Shares Outstanding | 159.24M | 157.76M | 156.44M | 155.23M | 154.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |